Drugs / Duraphat varnish®
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT06797882 Comparator | Jan 2025 → Aug 2026 overdue | enamel caries, smooth surface dental caries | National University of Malaysia | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT04342858 Comparator | Sep 2017 → Mar 2021 | dental caries | The University of Hong Kong | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Duraphat varnish | “Intervention 2 will receive standard OHI (every three months) and application of topical fluoride varnish containing 5% NaF (Duraphat varnish®, Colgate-Palmolive (UK) Ltd)...” NCT06797882 ↗1“Duraphat varnish®, Colgate-Palmolive (UK) Ltd., Guildford, Surrey, UK” NCT04342858 ↗ |
| Modality | Other / unclassified | “topical fluoride varnish containing 5% NaF” NCT04342858 ↗ |
| Route | Topical | “application of topical fluoride varnish” NCT04342858 ↗ |